Evidence map›Paper›PMID 36418565›Full record

Trial reportEuropean journal of nutrition2023

Changes in fatty acid levels after consumption of a novel docosahexaenoic supplement from algae: a crossover randomized controlled trial in omnivorous, lacto-ovo vegetarians and vegans.

Elena García-Maldonado, Alexandra Alcorta, Belén Zapatera, M Pilar Vaquero

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04278482 ("Diseño y Validación en Humanos de un Nuevo Complemento Alimenticio Rico en Ácido Docosahexaenoico), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04278482 nacompletednot on this map

"Diseño y Validación en Humanos de un Nuevo Complemento Alimenticio Rico en Ácido Docosahexaenoico (DHA) Procedente de Algas"

TypeinterventionalSponsorNational Research Council, SpainRan2020 to 2021Enrolled102ConditionsVegetarian DietArmsDietary supplement, DHA or Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elena García-MaldonadoDepartment of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 10, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-8043-2959
Alexandra AlcortaDepartment of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 10, 28040, Madrid, Spain.
Belén ZapateraDepartment of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 10, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-5930-6659
M Pilar VaqueroDepartment of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC, José Antonio Novais 10, 28040, Madrid, Spain. mpvaquero@ictan.csic.es.ORCID http://orcid.org/0000-0001-8828-5423
Instituto de Ciencia y Tecnología de Alimentos y Nutrición · ES

Funding

Comunidad de Madrid IND2018/BIO-9554
6 · The paper itself

Abstract

purposeTo determine serum fatty acids of lacto-ovo vegetarian (LOV), vegan (VEG) and omnivorous (OMN) adults, and to analyse the effects of consuming a docosahexaenoic acid (DHA) supplement of vegetable origin on fatty acid profile.

methodsA randomized, double-blind, placebo-controlled crossover design was conducted in healthy adults. Volunteers (n = 116) were randomly assigned to a DHA-supplement (dose 250 mg/day), made from the microalgae Schizochytrium sp., or a placebo during 5-week periods separated by a 5-week washout interim period. Compliance and dietary intake were estimated and serum fatty acids were determined by gas chromatography. Results were analysed by mixed linear models.

resultsPercentage of linoleic acid (C18:2n6) in serum was the highest among the fatty acids in the three diet groups, followed by oleic (C18:1n9) and palmitic (C16:0) acids. Linoleic (C18:2n6) and alpha-linolenic (C18:3n3) acids were higher in VEG compared to OMN (p < 0.001), while in LOV, their levels were intermediate between the other groups. Women presented higher DHA (C22:6n3) than men (p < 0.001). The DHA-supplement increased serum DHA compared to placebo in the three diet groups (p < 0.001), and a higher increase was observed in VEG followed by LOV (p < 0.001). The ratio serum n-6/n-3 improved by the supplementation but remained higher in LOV and VEG than in OMN. In contrast, the DHA-supplement decreased docosapentaenoic (C22:5n3) and docosatetraenoic (C22:4n6) acids in all diet groups (p < 0.001) and increased the eicosapentaenoic to alpha-linolenic fatty acids ratio (p = 0.016).

conclusionThe DHA-supplement at dose of 250 mg/day was effective in increasing serum DHA either in omnivorous, lacto-ovo vegetarian and vegan adults. CLINICAL

trial registrationRegistered at Clinicaltrials.gov ( www. CLINICALTRIALS: gov ), NCT04278482.

Indexed as

Fatty Acids, Omega-3VegansAdultalpha-Linolenic AcidDietary SupplementsDiet, VegetarianDocosahexaenoic AcidsFatty AcidsFemaleHumansMaleVegetariansalpha-Linolenic AcidDocosahexaenoic AcidsFatty AcidsFatty Acids, Omega-3Docosahexaenoic acidFatty acidsOmega-3Omega-6SupplementationVeganVegetarian

Identifiers

PMID36418565
PMCPMC9684969
OpenAlexW4309866982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.